Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India

Hdl Handle:
http://hdl.handle.net/10144/246593
Title:
Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India
Authors:
Sinha, Prabhat K; van Griensven, Johan; Pandey, Krishna; Kumar, Nawin; Verma, Neena; Mahajan, Raman; Kumar, Pankaj; Kumar, Ranjeet; Das, Pradeeb; Mitra, Gaurab; Flevaud, Laurence; Ferreyra, Cecilia; Remartinez, Daniel; Pece, Manuel; Palma, Pedro Pablo
Journal:
Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America
Abstract:
Reports on treatment outcomes of visceral leishmaniasis (VL)-human immunodeficiency virus (HIV) coinfection in India are lacking. To our knowledge, none have studied the efficacy of liposomal amphotericin B in VL-HIV coinfection. We report the 2-year treatment outcomes of VL-HIV-coinfected patients treated with liposomal amphotericin B followed by combination antiretroviral treatment (cART) in Bihar, India.
Affiliation:
Rajendra Memorial Research Institute of Medical Science, Patna, Bihar; Medecins Sans Frontieres–India, Operational Center Barcelona–Athens, New Delhi, India; Institute of Tropical Medicine, Antwerp, Belgium; Medecins Sans Frontieres, Medical Department, Operational Center Barcelona– Athens, Barcelona, Spain
Publisher:
Oxford University Press
Issue Date:
Oct-2011
URI:
http://hdl.handle.net/10144/246593
DOI:
10.1093/cid/cir521
PubMed ID:
21890763
Additional Links:
http://cid.oxfordjournals.org/content/53/7/e91.abstract
Type:
Article
Language:
en
ISSN:
1537-6591
Appears in Collections:
Leishmaniasis/Kala Azar

Full metadata record

DC FieldValue Language
dc.contributor.authorSinha, Prabhat Ken
dc.contributor.authorvan Griensven, Johanen
dc.contributor.authorPandey, Krishnaen
dc.contributor.authorKumar, Nawinen
dc.contributor.authorVerma, Neenaen
dc.contributor.authorMahajan, Ramanen
dc.contributor.authorKumar, Pankajen
dc.contributor.authorKumar, Ranjeeten
dc.contributor.authorDas, Pradeeben
dc.contributor.authorMitra, Gauraben
dc.contributor.authorFlevaud, Laurenceen
dc.contributor.authorFerreyra, Ceciliaen
dc.contributor.authorRemartinez, Danielen
dc.contributor.authorPece, Manuelen
dc.contributor.authorPalma, Pedro Pabloen
dc.date.accessioned2012-10-02T18:51:22Z-
dc.date.available2012-10-02T18:51:22Z-
dc.date.issued2011-10-
dc.identifier.citationClin Infect Dis 2011; 53(7):e91-e98en
dc.identifier.issn1537-6591-
dc.identifier.pmid21890763-
dc.identifier.doi10.1093/cid/cir521-
dc.identifier.urihttp://hdl.handle.net/10144/246593-
dc.description.abstractReports on treatment outcomes of visceral leishmaniasis (VL)-human immunodeficiency virus (HIV) coinfection in India are lacking. To our knowledge, none have studied the efficacy of liposomal amphotericin B in VL-HIV coinfection. We report the 2-year treatment outcomes of VL-HIV-coinfected patients treated with liposomal amphotericin B followed by combination antiretroviral treatment (cART) in Bihar, India.en
dc.language.isoenen
dc.publisherOxford University Pressen
dc.relation.urlhttp://cid.oxfordjournals.org/content/53/7/e91.abstracten
dc.rightsArchived with thanks to Clinical infectious diseases : an official publication of the Infectious Diseases Society of Americaen
dc.subject.meshAdolescenten
dc.subject.meshAdulten
dc.subject.meshAmphotericin Ben
dc.subject.meshAnti-HIV Agentsen
dc.subject.meshAntifungal Agentsen
dc.subject.meshAntiretroviral Therapy, Highly Activeen
dc.subject.meshFemaleen
dc.subject.meshHIV Infectionsen
dc.subject.meshHumansen
dc.subject.meshIndiaen
dc.subject.meshLeishmaniasis, Visceralen
dc.subject.meshMaleen
dc.subject.meshRecurrenceen
dc.subject.meshSurvival Analysisen
dc.subject.meshTreatment Failureen
dc.subject.meshTreatment Outcomeen
dc.titleLiposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, Indiaen
dc.typeArticleen
dc.contributor.departmentRajendra Memorial Research Institute of Medical Science, Patna, Bihar; Medecins Sans Frontieres–India, Operational Center Barcelona–Athens, New Delhi, India; Institute of Tropical Medicine, Antwerp, Belgium; Medecins Sans Frontieres, Medical Department, Operational Center Barcelona– Athens, Barcelona, Spainen
dc.identifier.journalClinical Infectious Diseases : an official publication of the Infectious Diseases Society of Americaen
All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.